Congo’s Ebola Death Toll Tops 500 as Health Workers Warn the Response Is Fraying

Congo’s Ebola Death Toll Tops 500 as Health Workers Warn the Response Is Fraying

The Ebola outbreak in the Democratic Republic of the Congo has crossed a grim threshold: more than 500 deaths have now been reported, and health workers in the hardest-hit province are warning that the response itself is under strain.

The DRC Ministry of Health has confirmed 1,561 cases and 506 deaths in the outbreak, according to CIDRAP’s July 6 summary of ministry figures, with the epicenter in Ituri province and significant transmission also reported in North Kivu and South Kivu. The latest count included 33 newly confirmed cases and 14 newly reported deaths. Neighboring Uganda has reported 20 confirmed cases, two of them fatal. The World Health Organization’s most recent Disease Outbreak News update, dated July 3, put the DRC count slightly earlier at 1,460 confirmed cases and 452 deaths as of July 1, with 20 confirmed cases and two deaths in Uganda as of July 2. Those numbers have been moving fast.

The story matters beyond the daily case count because this is not the best-known Ebola virus species. The outbreak is caused by Bundibugyo virus, one of the Ebola virus species that can cause severe disease in people. Unlike the Zaire Ebola virus, for which outbreak tools are better developed, Bundibugyo has no licensed vaccine or approved targeted treatment. That leaves the response leaning heavily on classic public health work: finding cases early, isolating patients safely, tracing contacts, protecting health workers, keeping communities informed, supporting families through safe burials, and maintaining trust in places already under pressure from conflict, displacement and fragile health services.

That basic machinery is exactly what may now be at risk. Health workers in Ituri issued a 24-hour strike notice on Sunday, CIDRAP reported, citing unpaid benefits, low wages and inadequate supplies since the outbreak officially began in May. A strike would be dangerous in any outbreak. In this one, it could be especially costly because the response is trying to scale up diagnostics, launch clinical trials and sustain contact tracing across a difficult, mobile and conflict-affected region.

WHO has assessed the risk in the DRC as “very high,” citing ongoing transmission and the expansion of the outbreak into new health zones. It rates the risk in Uganda as high because of confirmed cross-border spread and epidemiological links along the eastern DRC-western Uganda corridor. For the rest of the African region and globally, WHO currently assesses the risk as low. WHO has also advised against travel or trade restrictions on the DRC or Uganda based on currently available information.

A fast-moving outbreak in a hard place to contain one

The outbreak’s center of gravity remains Ituri province. In WHO’s July 3 update, Ituri accounted for 1,333 of the DRC’s 1,460 confirmed cases and 380 of 452 deaths reported nationally as of July 1. The highest case totals were reported in Bunia, Rwampara, Mongbwalu, Nyankunde and Nizi health zones. WHO said cases had been reported across 36 health zones in Ituri, North Kivu and South Kivu, with 21 health zones still active, meaning cases had been reported in the previous 21 days.

That distribution is a warning sign. Ebola control depends on speed and coverage: each case identified quickly, each contact followed daily through the incubation period, each health facility able to recognize symptoms and protect staff, each burial handled safely and respectfully. When transmission stretches across many health zones, every delay becomes more consequential.

WHO’s July 3 update said 10,821 contacts had been identified and were under follow-up in Ituri and North Kivu as of July 1, with follow-up rates of roughly 83% in Ituri and 81% in North Kivu. That is a large operation, but it also leaves room for missed chains of transmission. WHO noted that contact tracing remains difficult, and CIDRAP reported that a patient zero has still not been identified.

The geography and security context add another layer. WHO described the outbreak as unfolding in a “complex humanitarian and conflict-affected environment,” with highly mobile and often displaced populations lacking reliable access to food, clean water, shelter, health care and protection. It also cited security incidents affecting health facilities, constrained access for response teams and disrupted surveillance and response activities. Those are not background details. They are outbreak conditions.

In Uganda, the pattern is different so far. WHO said the last confirmed case there was identified on June 21. As of July 2, Uganda had reported 20 confirmed cases, including two deaths in imported cases, plus one probable case who died. Fifteen of the confirmed cases were imported, while five were secondary cases among contacts and health workers linked to imported cases from the DRC. WHO said there had been no documented community transmission in Uganda, with exposure risks tied to health care settings and cross-border movement.

France has also reported one linked case: a medical doctor who had returned from deployment in Ituri, where he had cared for patients with Bundibugyo virus disease. WHO said French authorities notified it of the laboratory-confirmed case on June 24. That case underscores the occupational risk for responders, but it does not change WHO’s current global risk assessment.

The tools are improving, but they are arriving mid-crisis

Two developments last week offered cautious hope. On July 2, WHO added the first molecular diagnostic test for Bundibugyo virus to its Emergency Use Listing. The test identifies the virus’s genetic material in blood samples, allowing infection to be confirmed rapidly and accurately. WHO said the emergency listing is meant to help countries and procurement agencies access tools that meet minimum standards for quality, safety and performance during a public health emergency.

That matters because early testing shapes nearly everything else. A confirmed diagnosis can speed isolation, guide clinical care, trigger contact tracing and help surveillance teams see where the outbreak is moving. CIDRAP noted that experts suspect some testing in the DRC earlier in the spring may have missed early Bundibugyo infections because tests were focused on the more common Zaire strain.

Testing capacity has improved substantially. WHO said that with support from WHO and the Africa Centres for Disease Control and Prevention, laboratory capacity expanded from a limited number of sites — mainly the Institut National de Recherche Biomédicale in Kinshasa and Goma, with an estimated combined capacity of about 200 to 400 tests per day — to a network of 10 laboratories across affected provinces, with reported capacity above 2,000 tests per day.

The second development is therapeutic research. Also on July 2, WHO announced that patient enrollment had begun in the PARTNERS clinical trial in the DRC. The trial will evaluate whether two antiviral therapies — the monoclonal antibody MBP134 and remdesivir — can improve survival among people diagnosed with Bundibugyo virus disease. It will also assess whether combining the two provides additional benefit.

The trial is sponsored by WHO and coordinated by the DRC’s Institut National de Recherche Biomédicale, the Institute of Tropical Medicine in Belgium and the University of Oxford, with international research, clinical and humanitarian partners and support from Africa CDC. People enrolled will receive close support and at least 28 days of follow-up. Participating treatment units will provide early supportive care, including fluids, electrolyte replacement, oxygen support, blood pressure management and pain control in line with WHO guidance.

The important caveat: these are investigational treatments. They are not proven cures. WHO has said that while effective treatments exist for Ebola virus disease caused by some other virus species, none are currently approved for Bundibugyo virus disease, and no treatment has been shown to work across all virus types that cause Ebola diseases. That is why the trial matters. It is an attempt to generate evidence during the outbreak, not after communities have already paid the cost.

The labor warning could become the response’s biggest immediate risk

The strike threat from Ituri health workers turns the story from a disease update into a systems test. Case counts often dominate Ebola coverage, but outbreaks are beaten by people: nurses, hygienists, laboratory staff, burial teams, contact tracers, ambulance drivers, community engagement workers, data teams, translators, cleaners and local leaders who persuade frightened families that early care is safer than hiding illness.

If those workers lack pay, supplies or protection, the response slows. If they lose trust in the institutions managing the response, community trust can erode with it. In Ebola outbreaks, trust is not a soft add-on. It determines whether people report symptoms, accept monitoring, permit safe burials, seek care early and share accurate contact lists.

The DRC and WHO acknowledged that community engagement is central in a May 31 joint statement after a high-level mission to Bunia. They said national and provincial authorities, with WHO and partners, were intensifying dialogue with community leaders, women’s groups, youth representatives, religious leaders and the private sector to understand local concerns and co-develop culturally appropriate solutions. The statement also listed persistent challenges: early detection and isolation of cases, contact tracing, safe and dignified burials, infection prevention and control in health facilities, and strong community awareness.

Those priorities are not abstract. They are also exactly the areas that become harder when frontline workers are exhausted, under-equipped or preparing to walk out.

A continental plan, and a funding question

Africa CDC and WHO launched a joint continental preparedness and response plan on June 5, aiming to raise $518 million for a six-month response from June through November. The plan covers emergency coordination, surveillance, laboratory testing, infection prevention and control, clinical care, community engagement, research, logistics and support for essential health services.

The “One Response” framing is deliberate. Ebola does not respect provincial or national borders, and the DRC-Uganda corridor has a history of population movement tied to trade, health care, family networks and mining. WHO’s risk assessment specifically cites cross-border mobility and uneven readiness among neighboring countries as reasons for high risk in countries sharing land borders with areas of documented Bundibugyo virus detection.

The plan also warns against tunnel vision. The region is responding not only to Ebola but also to other health emergencies, including mpox, cholera and measles. An Ebola response that drains staff, money or attention from routine care can leave communities vulnerable in other ways. That is why WHO and DRC officials have emphasized maintaining primary health care and essential services even while emergency operations accelerate.

For readers far from Central Africa, the right takeaway is not panic. WHO’s current global risk assessment is low, and it does not recommend travel or trade restrictions. The right takeaway is that outbreak control is a public good that depends on early financing, diagnostics, worker protection, transparent communication and sustained community partnership. Waiting until a pathogen is at the airport is the least efficient way to care about it.

What to watch next

The immediate indicators are practical. First, whether the Ituri labor dispute is resolved quickly enough to keep case investigation, treatment and contact tracing moving. Second, whether the new diagnostic capacity shortens the time between symptoms, testing and isolation. Third, whether the PARTNERS trial can enroll patients safely and ethically while health teams remain under pressure. Fourth, whether Uganda continues to avoid community transmission. Fifth, whether the $518 million continental plan attracts enough support to sustain response work beyond emergency announcements.

The outbreak’s numbers will keep changing. The underlying question is whether the response can move faster than the virus in places where the health system is already stretched. The DRC has deep Ebola experience, and WHO, Africa CDC and local partners have brought new tools to the field. But this week’s milestone — more than 500 deaths, rising cases and a threatened strike in Ituri — is a reminder that biomedical tools are only as strong as the people and systems that can deliver them.

Sources

• WHO Disease Outbreak News, July 3, 2026: Ebola disease caused by Bundibugyo virus, Democratic Republic of the Congo & Uganda
• CIDRAP, July 6, 2026: Ebola deaths top 500 as DR Congo health workers threaten to strike
• WHO, July 2, 2026: WHO adds first diagnostic test for Ebola Bundibugyo virus to its Emergency Use Listing
• WHO, July 2, 2026: Patient enrolment begins in a scientific trial to identify the first effective treatments for Bundibugyo virus disease
• WHO and Africa CDC, June 5, 2026: Africa CDC and WHO launch joint continental Ebola response plan
• Government of the DRC and WHO, May 31, 2026: Joint statement on the outbreak of Ebola disease caused by the Bundibugyo virus